Thursday, June 4, 2015

Infertility and Ovarian Cancer

As part of treating ovarian cancer, many women lose one or both ovaries. In either case, women who’ve been treated for ovarian cancer may be infertile. While many women who develop ovarian cancer are past the age when they can have children, not everyone is. Cobie Smulders is a celebrity example of a person who had ovarian cancer, but went on to have children.



Because every case is different, women with ovarian cancer may want to know their options. Fortunately, there could be many different venues for women with ovarian cancer to maintain fertility. Here is some information on how ovarian cancer can affect fertility in women from the University of Rochester Medical Center:

“Fertility refers to your ability to produce children. Some women who are treated for ovarian cancer still maintain their fertility, while others don’t.

You may still be able to become pregnant if you have only one ovary removed to treat the cancer. Keeping your fertility options while maintaining the healing potential of the treatment required for ovarian cancer can often be a complicated management decision. It is very important that your particular findings be put into context by an expert. Gynecologic oncologists are subspecialists with advanced training in the diagnosis, treatment, and surveillance of female cancers including ovarian cancer.

You may be infertile, meaning you cannot become pregnant without medical intervention, if you had any of these treatments for ovarian cancer:

Surgery to remove both of your ovaries.

Chemotherapy. Many chemotherapy drugs can cause the menstrual cycle to stop and disrupt the function of your ovaries.

Radiation directed at your pelvic area. Radiation can affect your ovaries’ ability to produce a mature egg.

If you had any of these treatments and you want to have children, see a reproductive endocrinologist. This is a doctor who specializes in infertility treatment. A multidisciplinary team approach, which includes a gynecologic oncologist and a reproductive endocrinologist, may be required.”

Learn more about treatment options by reading the entire article here: http://www.urmc.rochester.edu/encyclopedia/content.aspx?ContentTypeID=34&ContentID=19758-1

Wednesday, May 27, 2015

New Cancer Biomarkers for Ovarian Cancer Could Aid Detection Efforts



When it comes to detecting cancers, ovarian cancer has long been proclaimed one of the hardest cancers to find. That’s because it’s usually fairly advanced before it’s found and can be treated. However, new research is finding new biomarkers for ovarian cancer, which could help doctors identify and treat it. According to a recent news article,

“UC San Diego researchers say they have found a potential new diagnostic for ovarian cancer, one of the most difficult cancers to detect and treat.

The discovery of six isoforms of messenger RNA specific to ovarian cancer could also lead to new therapies, the researchers say in a study published Monday in the Proceedings of the National Academy of Sciences. (If the article is not yet live, please check back later).

Christian L. Barrett was the study's first author; the senior author was Kelly A Frazer.

Ovarian cancers typically don't show symptoms until well-established. While most respond to therapy at first, recurrences become progressively more difficult to treat.

Scientists at UCSD School of Medicine and Moores Cancer Center used bioinformatics to screen public genetic databases sponsored by the NIH, eventually finding six mRNA isoforms that were reliably present in 296 ovarian cancer samples but not present in 1,839 normal tissue samples. These molecules are specific enough to be used in a test for the early detection of ovarian cancer, the scientists said.

Moreover, some of the mRNA code for proteins representing potential new therapeutic targets, the paper found.

"We were inspired by many studies aimed at using DNA to detect cancer," Barrett said in a UCSD press release. "But we wondered if we could instead develop an ovarian cancer detection test based on tumor-specific mRNA that has disseminated from cancer cells to the cervix and can be collected during a routine Pap test."

The researchers validated their findings by searching for and finding these mRNA isoforms in ovarian cancer cells grown in the lab. They suggest that similar testing could be done for 30 other cancers in which sufficient amounts of mRNA have already detected.”


Read the full article here: http://www.utsandiego.com/news/2015/may/25/ovarian-cancer-ucsd/

Thursday, May 21, 2015

Detecting Ovarian Cancer Just Got Easier



Ovarian cancer is known as the silent killer because its symptoms often mask as other problems until the disease is quite advanced. Pain can be “waved away” as stomach pain or run-of-the-mill reproductive pain. That’s why it’s so critical for ovarian cancer detection methods to improve. Fortunately, one research team is working on the problem:

“Detection of ovarian cancer was significantly improved in a study that used a risk algorithm based on changes in serum cancer antigen 125 (CA125) levels over time rather than relying on traditional fixed CA125 cutoff values.

As part of the ongoing United Kingdom ovarian cancer trial involving more than 200,000 women, researchers found that the risk algorithm could detect 87% of ovabrian cancers, compared with fewer than 50% of cancers identified using cutoff values.

The findings could substantially improve the early detection of ovarian cancer, which is associated with 6-month survival rates of less than 5% if it is diagnosed at an advanced stage, say the researchers.”

Read the original article at Medscape: http://www.medscape.com/viewarticle/844673

Tuesday, May 12, 2015

Good News: Ovarian Cancer Death Rates Drop

New studies have shown tremendous improvements in ovarian cancer outlooks for patients over the past half-century. Advances in medical care mean that women who are diagnosed with the disease, called the “silent killer,” are more able to be treated. Better options in healthcare, chemotherapy, and surgery are helping to boost survival rates for women. According to the study:



“Women diagnosed with ovarian cancer, traditionally viewed as an aggressive killer, are much more likely to survive the disease than they were several decades ago, new research shows.

"Ovarian cancer, unfortunately, is associated with a very high death rate," said study author Dr. Jason Wright, a professor of obstetrics and gynecology at Columbia University College of Physicians and Surgeons in New York City.

But that seems to be changing, he said.

"We wanted to do this study because there have been a number of advances in the treatment of ovarian cancer," Wright said. "There is better surgery, better chemo and better ways to deliver the chemo. More recently, there has also been a better understanding of the biology and genetics of the cancer."

To see if these advances have made an impact on survival rates, Wright's team evaluated nearly 50,000 women who were diagnosed with the disease between 1975 and 2011. All of the data came from a large national cancer database.

"We compared survival for women with cancer compared to women without cancer [in the general population]," he said.

After accounting for advances in general medical care, Wright said, "women diagnosed in 2006 compared to those diagnosed in 1975 are about 50 percent less likely to die from their ovarian cancer."

Survival improved for all stages of ovarian cancer from 1975 to 2011, Wright found. Women with stage 1 cancers were 49 percent less likely to die of the cancer in 2006. Those with stage 3 and 4 cancers were about 51 percent less likely to die.”

Read the entire article here: http://www.webmd.com/ovarian-cancer/news/20150507/study-sees-improving-survival-odds-for-ovarian-cancer

Thursday, May 7, 2015

Celebrating World Ovarian Cancer Day 2015


We're so excited to celebrate World Ovarian Cancer Day on May 8th! This year, the event is promoting the #UnbreakableBond campaign, hoping to help women band together to raise awareness about ovarian cancer. According to an article at EmpowHer,

"May 8, 2015, will be the third annual World Ovarian Cancer Day. The first day was observed in 2013, by an international group of representatives from patient organizations working in ovarian cancer. The organization is dedicated to creating and raising awareness about ovarian cancer to ensure all women know about the disease. 
Calaneet Balas, CEO of OCNA, strongly believes in supporting those women affected by this devastating disease. Balas believes that cancer still carries a big stigma in many countries around the world, especially when it comes to women. Due to limited treatment options and low survival rates, many women often feel loneliness and abandonment along with their cancer diagnosis rather than receiving the support they really need at this time from family and friends. If ovarian cancer is found and treated before the cancer spreads outside of the ovaries, the five-year survival rate is 92 percent, but only 15 percent of all ovarian cancer cases are found at this early stage, the American Cancer Society said. 
"In some countries they talk about cancer, but they don't talk about women's cancer, and gynecologic cancer is still taboo across the board. We certainly don't talk about it here in the United States," Balas said. 
By coming together since the first meeting, the World Ovarian Cancer Day group "has built and will continue to build a sense of solidarity in the fight against the disease," Balas said. The group has been addressing gaps in understanding and managing the disease, building awareness and increasing funds for research."

You can read the whole article  here, and help us raise awareness for ovarian cancer on our Facebook page here!

Wednesday, April 29, 2015

Could a New Blood Test Detect Ovarian Cancer?



A new method of testing for ovarian cancer could eventually help more patients be detected earlier. Because ovarian cancer’s symptoms are often not readily apparent until the disease is advance, it’s known as the “silent killer.” New tests would help save lives, particularly those that aid with early detection. Here’s more information about the new test:

“A simple blood test for ovarian cancer which detected tumour cells in four out of five patients could be available next year.
The test was further refined for use in seven patients, detecting all cases of ovarian cancer, according to results from the Medical University of Vienna.
The detection rate is superior to current methods used to monitor women at inherited risk of ovarian cancer, including a blood marker test that has a reliability rate as low as 50 per cent for early stage disease.

Blood samples are analysed in a cell separation device called Parsortix, which picks up cancer cells and also harvests them so they can be analysed to determine the best treatment for the patient.
UK charities said the results were ‘encouraging’ and could eventually lead to earlier diagnosis through screening of high-risk women.
Ovarian cancer is known as the ‘silent killer’ because women are often diagnosed too late for a cure.
Ovarian cancer affects almost 7,000 women a year and kills more than 4,000 women - claiming the lives of over 85 per cent of patients if found at a late stage when it has spread to other parts of the body.

In a new pilot study, presented at the American Association for Cancer Research Annual Meeting 2015 in Philadelphia, the test picked up cancer cells in 80 per cent of 42 patients with ovarian cancer.
After the test was refined 100 per cent of cancers were picked up in seven ovarian cancer patients.
Experts hope the test will assist women – like Angelina Jolie - at high risk of developing ovarian and breast cancer because of inherited BRCA gene defects.
At present some opt for preventive surgery with removal of the breasts and ovaries to reduce the risk, but close monitoring using a blood test might provide an alternative.
The university researchers presented the case of a high risk patient who carried BRCA gene mutations.”


Friday, April 24, 2015

Can Delayed Pregnancy Reduce Ovarian Cancer Risk?



According to a new study, giving birth later in life could help reduce ovarian cancer risks. This may conflict with earlier findings that giving birth more often is also correlated with having a low risk of ovarian cancer. The study shows that women who give birth in their mid-30s or later may have a lowered risk of developing ovarian cancer, and that women’s risk may decrease over time. The study says:

“The researchers found that each five-year increase in a woman's age at the birth of her first child corresponded to a 16 percent lower risk of ovarian cancer. So, for example, women who gave birth to their first child at age 35 or later had a 46 percent decrease in their risk of ovarian cancer compared with women who gave birth to their first child when they were younger than 20.

The findings held even after the researchers took into account other factors that could affect a woman's risk of ovarian cancer, such as the total number of babies she has had and her use of oral contraception. [5 Things Women Should Know About Ovarian Cancer]

Previous studies have found that women who give birth to more children are at lower risk for ovarian cancer. One hypothesis for the link is that, during pregnancy, women stop ovulating, or releasing an egg each month. Regular ovulation is thought to increase the risk of ovarian cancer because it damages the lining of the ovaries, so the ovary cells need to be repaired frequently, which can increase the chance for cancer-causing changes to occur.

But the new findings suggest that there are factors other than the stopping of ovulation during pregnancy that reduce ovarian cancer risk, said study researcher Alice Lee, a doctoral student at the University of Southern California, who presented the findings here this week at the annual meeting of the American Association for Cancer Research.

"The fact that the timing [of the pregnancy] matters kind of shows there's a little bit more to this" link between ovulation and ovarian cancer," Lee told Live Science.

It's not exactly clear why the timing of birth matters for protection against ovarian cancer. But when women are pregnant, they experience an increase in levels of the hormone progesterone, which triggers some cells to self-destruct. Because older women have accumulated more damage to the cells that line the ovaries, a later first pregnancy could clear more of this damage.

"If you have a later age at first birth, you essentially are able to clear more of the malignancy-transformed cells," Lee said.

It's too early to say whether the findings are "good news" for women who delay pregnancy, as an increasing number of women are doing. More research is needed to replicate the findings, Lee said.”